Insights

Here’s why the Creso Pharma (ASX:CPH) share price is surging 15% higher

This cannabis company is on a high today…
The post Here’s why the Creso Pharma (ASX:CPH) share price is surging 15% higher appeared first on The Motley Fool Australia. –

The Creso Pharma Ltd (ASX: CPH) share price has been a very strong performer on Thursday.

In early trade, the cannabis and psychedelics company’s shares are up 15% to 15 cents.

Why is the Creso share price surging higher?

Investors have been bidding the Creso Pharma share price higher this morning following the release of an update on an acquisition.

According to the release, the company has completed the acquisition of Canadian psychedelics company Halucenex Life Sciences following a period of due diligence.

Management believes the acquisition marks an important milestone, as it provides direct access to the emerging psychedelic-assisted psychotherapy (PAP) sector. It also notes that it unlocks a number of near term opportunities and access to additional lucrative market verticals.

Management highlights that there has been a growing body of evidence demonstrating that psychedelic medicines are safe and non-addictive when used in medical settings. In a number of clinical trials completed in recent years, psychedelic-assisted psychotherapy has produced some significant, long-lasting clinical outcomes for individuals living with mental health conditions.

It feels there is potential for psychedelic-assisted therapy to be commercialised as a safe and effective treatment which provides a solution to the growing global mental health crisis.

Management commentary

Creso’s Non-executive Chairman, Adam Blumenthal, was very pleased with the news.

He said: “Completing the acquisition of Halucenex is a major milestone for Creso Pharma and we will now pursue a number of near term value creation strategies through the subsidiary and in preparation of the proposed merger with Red Light Holland.”

“This acquisition has allowed Creso Pharma to emerge as a best-in-class provider of cannabis, cannabinoids and alternative psychedelics solutions to meet a large and unmet demand to improve mental health and wellbeing.”

Despite this strong gain, the Creso Pharma share price is still down 16% since this time last month. Concerns over the aforementioned proposed merger with Red Light Holland have been weighing heavily on the Creso Pharma share price.

The post Here’s why the Creso Pharma (ASX:CPH) share price is surging 15% higher appeared first on The Motley Fool Australia.

Should you invest $1,000 in Creso Pharma right now?

Before you consider Creso Pharma, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Creso Pharma wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

Blazing it? How the top ASX cannabis shares performed in FY21

Why the Creso Pharma (ASX:CPH) share price is zooming higher
Why Coles, Creso Pharma, Ramelius, & Whitehaven Coal are tumbling lower

Creso Pharma (ASX:CPH) share price sinks on Red Light Holland merger plans

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
Trade The US Market With ZERO Brokerage* + FREE Access To Trading Ideas & Value Analysis Tools. Click Here!